Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate belongs to the dihydropyridine class of calcium‑channel blockers. It inhibits L‑type calcium channels in vascular smooth muscle, leading to arterial vasodilation, decreased peripheral resistance, and ultimately a reduction in systolic and diastolic blood pressure.

The dosage of Nesyrgy is individualized by the prescribing clinician based on the patient’s blood pressure, age, renal and hepatic function, and concomitant therapies. The prescriber determines the appropriate strength and frequency to achieve optimal blood pressure control.

Safety data for Nesyrgy in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Nesyrgy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nesyrgy combines a calcium‑channel blocker with a highly selective β1‑blocker, offering complementary mechanisms that can provide more consistent blood pressure control than monotherapy. Compared with single‑agent agents, the combination may reduce the need for multiple pills, but individual response and tolerability should guide therapy choice.

Store Nesyrgy at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure they are out of reach of children.

Nesyrgy is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a full glass of water and follow the dosing schedule prescribed by their healthcare professional.

Serious risks include severe hypotension, marked bradycardia, heart block, and allergic reactions such as rash or angioedema. Patients experiencing dizziness, fainting, rapid heartbeat changes, or signs of an allergic response should seek immediate medical attention.

Nesyrgy is contraindicated in patients with known hypersensitivity to amlodipine, nebivolol, or any excipients, as well as those with severe aortic stenosis, uncontrolled heart failure, or cardiogenic shock. Caution is also advised for individuals with significant liver impairment or certain cardiac conduction disorders.